CBD is super trendy. This molecule (which is also called “cannabidiol” in medical language) belongs to the cannabinoid family: extracted from hemp, it has no psychotropic effect and does not cause any addiction. The World Health Organization (WHO) even believes that cannabidiol (CBD) may possess “some therapeutic value for epileptic seizures and related diseases“.
Precisely: according to a recent study carried out by the Medical College of Georgia at Augusta University (in the United States), inhaling CBD could be of interest in the management of glioblastoma, a brain cancer of which there are 2400 new diagnoses every year in France.
CBD may help reduce tumor volume
American researchers worked with mice with glioblastoma. These were separated into two groups: the mice in group 1 were given a daily dose of inhaled CBD while the mice in group 2 were only given a placebo.
After 7 days of observation, the scientists observed a reduction in the volume of the tumor in the mice of group 1 as well as a change in the tumor environment, which was not favorable to the growth of the brain tumour.
“Inhaled CBD is very interesting because, on the one hand, it quickly reaches the brain via the respiratory tractanalyze the researchers who published their work in the specialized journal Cannabis and Cannabinoid Research. On the other hand, it is as easy to use as an asthma inhaler, for example.”
Glioblastoma unfortunately suffers from a rather bleak vital prognosis since the 5-year survival rate is less than 10%. Recurrences are also frequent.
Read also :
- Glioblastoma: what treatments for this brain tumour?
- Brain cancer: soon a vaccine against glioblastoma?
- Brain tumour: 9 cases of glioblastoma recorded in Gard
